U.S., April 19 -- ClinicalTrials.gov registry received information related to the study (NCT06933199) titled 'Neoadjuvant Stereotactic Radiotherapy for Brain Metastasis' on April 03.
Brief Summary: This multicentre proof-of-concept study, involving 4 centers, aims to establish the value of fractionated neoadjuvant stereotactic radiotherapy (NaSRT) as a new treatment paradigm for brain metastases (BM) in the frame of the Czech neurooncology network. Most relevant studies published to date used single-fraction radiotherapy and dealt with the inherent bias related to their retrospective nature. The researchers aim to increase the level of evidence for this treatment paradigm together with other similar ongoing studies.
Study Start Date: May ...